Document:

Prepared by MERRILL CORPORATION www.edgaradvantage.com

QuickLinks
 -- Click here to rapidly navigate through this document
 

UNITEDHEALTH GROUP INCORPORATED

$400,000,000 7.50% Notes due November 15, 2005  

  Officers' Certificate and Company Order         

    Pursuant to the senior debt securities Indenture dated as of November 15, 1998, as amended by an Amendment to Indenture dated November 6, 2000
(collectively, the "Indenture"), between UnitedHealth Group Incorporated, a Minnesota corporation (the "Company"), and The Bank of New York, as Trustee (the "Trustee") and resolutions adopted by the
Company's Executive Committee of the Board of Directors on October 20, 1998, this Officers' Certificate is being delivered to the Trustee to establish the terms of a series of Securities in
accordance with Section 301 of the Indenture, to establish the form of the Securities of such series in accordance with Section 201 of the Indenture, to request the authentication and
delivery of the Securities of such series pursuant to Section 303 of the Indenture and to comply with the provisions of Section 104 of the Indenture. This Officers' Certificate shall be
treated for all purposes under the Indenture as a supplemental indenture thereto. 

    All
conditions precedent provided for in the Indenture relating to (i) the establishment of a series of Securities, (ii) the establishment of the form of Securities of
such series and (iii) the procedures for authentication and delivery of such series of securities have been complied with. 

    Capitalized
terms used herein and not otherwise defined herein shall have the meanings assigned to them in the Indenture. 

    A.  Establishment of a series of Securities pursuant to Section 301 of the Indenture.  

    There
is hereby established pursuant to Section 301 of the Indenture a series of Securities which shall have the following terms: 

    (1) The
Securities shall bear the title "7.50% Notes due November 15, 2005" (referred to herein as the "Notes"). 

    (2) The
aggregate principal amount of the Notes to be issued pursuant to this Officers' Certificate and Company Order shall be limited to $400,000,000 except for
(a) Notes authenticated and delivered upon registration of, transfer of, or in exchange for, or in lieu of, other Notes pursuant to Section 304, 305, 306, 1007 or 1205 of the Indenture,
(b) Notes which, pursuant to Section 303 of the Indenture, are deemed never to have been authenticated and delivered thereunder and (c) any Securities of this series which are
issued in the manner contemplated by paragraph 18 hereof. 

    (3) Interest
will be payable to the Person in whose name a Note (or any Predecessor Security) is registered at the close of business on the Regular Record Date (as
defined below) immediately preceding each Interest Payment Date (as defined below). If any Interest Payment Date or date of Maturity of the Notes falls on a day which is not a Business Day (as defined
below), the related payment of principal or interest shall be made on the next succeeding Business Day with the same force and effect as if made on the date such payment was due, and no interest shall
accrue on the amount so payable for the period from and after such Interest Payment Date or date of Maturity, as the case may be. "Business Day" shall mean any day other than a Saturday, a Sunday or a
day on which banking institutions in The City of New York or Minneapolis, Minnesota or at a place of payment are authorized or obligated by law, regulation or executive order to remain closed. 

    (4) The
Stated Maturity Date of the Notes shall be November 15, 2005. 

    (5)(A) The
Notes shall bear interest at the rate of 7.50% per annum (based upon a 360-day year of twelve 30-day months), from
November 16, 2000 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, as the case may be, payable semi-annually on May 15 and
November 15 in each year, commencing May 15, 2001, until the principal thereof is paid or made available for payment. Each such May 15 and November 15 shall be an "Interest
Payment Date" for the Notes, and each May 1 and November 1 (whether or not a 

Business Day), as the case may be, immediately preceding an Interest Payment Date for the Notes shall be the "Regular Record Date" for the interest payable on such Interest Payment Date. 

    (5)(B) The
provision related to interest on overdue principal in Section 501 of the Indenture shall not be applicable to the Notes. 

    (6) Principal
of (and premium, if any) and interest on the Notes will be payable, and, except as provided in Section 305 of the Indenture with respect to a
Global Security (as defined below), the transfer of the Notes will be registrable and Notes will be exchangeable for Notes bearing identical terms and provisions at the corporate trust office of The
Bank of New York, in the City of New York, New York, provided, however, that payment of principal or interest may be made at the option of the Company
by check mailed to the Person entitled thereto as shown on the Security Register. 

    (7) The
Notes will be redeemable as follows: 

    The
Notes will be subject to redemption, in whole or in part at any time before their Stated Maturity, at the option of the Company at a Redemption Price equal to the greater of
(i) 100% of the principal amount of the Notes to be redeemed and (ii) the sum of the present values of the remaining scheduled payments of principal and interest on the Notes to be
redeemed (excluding the portion of any such interest accrued to the Redemption Date) discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year
consisting of twelve 30-day months) at the Treasury Yield (as defined below), plus 25 basis points, plus, in each case, accrued and unpaid interest to the Redemption Date. For this
purpose, the following terms have the following meanings: 

	•
	"Treasury
Yield" means, with respect to any Redemption Date, the rate per year equal to the semi-annual equivalent yield to maturity of the
Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such Redemption Date.

	•
	"Comparable
Treasury Issue" means, the United States Treasury security selected by an Independent Investment Banker as having a maturity comparable to the
remaining term of the Notes that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable
maturity to the remaining term of the Notes.

	•
	"Comparable
Treasury Price" means, with respect to any Redemption Date, (i) the average of the bid and asked prices for the Comparable Treasury
Issue (expressed in each case as a percentage of its principal amount) on the third business day preceding such Redemption Date, as set forth in the daily statistical release (or any successor
release) published by the Federal Reserve Bank of New York and designated "Composite 3:30 Quotations for U.S. Government Securities" or (ii) if such release (or any successor release) is not
published or does not contain such prices on such business day, (A) the average of the Reference Treasury Dealer Quotations for such Redemption Date, after excluding the highest and lowest such
Reference Treasury Dealer Quotations for such Redemption Date, or (B) if the
Trustee obtains fewer than four such Reference Treasury Dealer Quotations, the average of all such Reference Treasury Dealer Quotations.

	•
	"Independent
Investment Banker" means Goldman, Sachs & Co. or its successor or, if such firm is unwilling or unable to select the Comparable
Treasury Issue, one of the remaining Reference Treasury Dealers appointed by the Trustee after consultation with the Company. 

2

	•
	"Reference
Treasury Dealer" means (i) each of Goldman, Sachs & Co. and any other primary U.S. Government securities dealer in New York City
(a "Primary Treasury Dealer") designated by, and not affiliated with, Goldman, Sachs & Co., provided, however, that if Goldman, Sachs &
Co. or any of its designees shall cease to be a Primary Treasury Dealer, the Company will appoint another Primary Treasury Dealer as a substitute for such entity and (ii) any other Primary
Treasury Dealer selected by the Trustee.

	•
	"Reference
Treasury Dealer Quotations" means, with respect to each Reference Treasury Dealer and any Redemption Date, the average, as determined by the
Company, of the bid and asked prices for the Comparable Treasury Issue (expressed, in each case, as a percentage of its principal amount) quoted in writing to the Trustee by such Reference Treasury
Dealer at 5:00 p.m. on the third business day preceding such Redemption Date.

	•
	"business
day" means any day that is not a Saturday or Sunday and that, in the City of New York, is not a day on which banking institutions are generally
authorized or obligated by law to close. 

    A
notice of redemption may provide that it is subject to certain conditions that will be specified in the notice. If those conditions are not met, the redemption notice will be of no
effect and the Company will not be obligated to redeem the Notes. 

    A
partial redemption of the Notes may be effected on a pro rata basis (and in such manner as complies with applicable legal and stock exchange requirements, if any) or in such method
as the Trustee, in the exercise of its reasonable discretion, deems fair and appropriate. The trustee may provide for the selection for redemption of portions in amounts of $1,000 or whole multiples
of $1,000;
except that if all of the Notes of a Holder are to be redeemed, the entire outstanding amount of Notes held by such Holder, even if not a multiple of $1,000, shall be redeemed. 

    Notice
of any redemption will be mailed at least 30 days but not more than 60 days before the Redemption Date to each Holder of the Notes to be redeemed. 

    Unless
any Note called for redemption shall not be paid upon surrender thereof for redemption, on and after the Redemption Date interest will cease to accrue on the Notes or portions
thereof called for redemption. 

    (8) The
Company shall not be obligated to redeem or purchase any Notes pursuant to any sinking fund or analogous provisions or at the option of the Holder. 

    (9) The
Notes shall not be convertible into shares of Common Stock of the Company or exchangeable for any other securities. 

   (10) The
Trustee shall be the Security Registrar and the Paying Agent. 

   (11) The
amount of payments of principal of and any premium or interest on the Notes will not be determined with reference to an index. 

   (12) The
Notes shall be subject to the covenants and definitions set forth in the Indenture. 

   (13) The
Notes will be issued only in fully registered form and the minimum initial purchase amounts of the Notes shall be $1,000 and any integral multiple of $1,000 in
excess thereafter. 

   (14) The
Notes shall be subject to the Events of Default specified in Section 701, paragraphs (i) through (viii), of the Indenture. 

3

   (15) The portion of the principal amount of the Notes which shall be payable upon declaration of acceleration of maturity thereof shall not be less than the principal
amount thereof. 

   (16) The
Notes will be deposited with, or on behalf of, The Depository Trust Company, New York, New York, as Depositary, and will be represented by a global security (a
"Global Security") registered in the name of a nominee of the Depositary. So long as the Depositary or its nominee is the registered holder of any Global Security, the Depositary or its nominee, as
the case may be, will be considered the sole Holder of the Notes represented by such Global Security for all purposes under the Indenture and the Notes. 

   (17) The
defeasance provisions set forth in Sections 902 and 903 of the Indenture shall apply to the Notes. 

   (18) The
Company may, so long as no Event of Default has occurred, without the consent of the Holders of the Notes, issue additional notes with the same terms as the
Notes in accordance with the corporate authority existing at the time of such additional issuance, and such additional notes shall be considered part of the same series under the Indenture as the
Notes. The Notes shall have such other terms and provisions as are provided in the Global Security representing the Notes substantially in the form attached as Exhibit A hereto. 

   (19) The
CUSIP number for the Notes is 91324 PAA 0. 

    B.  Establishment of Forms of Securities Pursuant to Section 201 of Indenture.  

    It
is hereby established pursuant to Section 201 of the Indenture that the Global Security representing the Notes shall be substantially in the form attached as
Exhibit A hereto. 

    C.  Order for the Authentication and Delivery of Securities Pursuant to Section 303 of the
Indenture.  

    It
is hereby ordered pursuant to Section 303 of the Indenture that the Trustee authenticate, in the manner provided by the Indenture, the Notes in the aggregate principal
amount of $400,000,000 registered in the name of Cede & Co., which Notes have been heretofore duly executed by the proper officers of the Company and delivered to you as provided in the
Indenture, and to deliver said authenticated Notes to or on behalf of The Depository Trust Company on or before 9:00 a.m., Eastern Standard Time, on November 16, 2000. 

    D.  Other Matters.  

    Attached
as Exhibit B hereto are true and correct copies of resolutions adopted by the Board of Directors of the Company at a meeting on August 4, 1998 and resolutions
adopted by the Executive Committee of the Board of Directors of the Company by written action effective October 20, 1998; such resolutions have not been further amended, modified or rescinded
and remain in full force and effect; and such resolutions (together with this Officers' Certificate) are the only resolutions or other action adopted by the Company's Board of Directors or any
committee thereof or by any officers of the Company relating to the offering and sale of the Notes. 

    The
undersigned Vice President and Treasurer being an Authorized Representative as defined in the resolutions of the Executive Committee of the Board of Directors of the Company
adopted at a meeting on October 20, 1998 certifies that (i) he has approved the terms of the Notes as set forth in this Officers' Certificate, (ii) he has approved and ratified
the terms and form of the Underwriting Agreement dated November 13, 2000 and the Pricing Agreement dated November 13, 2000 (the "Pricing Agreement") between the Company and Goldman,
Sachs & Co. and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representatives of the several Underwriters named in Schedule I to the Pricing
Agreement and (iii) he has approved and ratified the Indenture, all in accordance with the authority of such officer pursuant to such resolutions. 

4

    The undersigned have read the pertinent sections of the Indenture including the related definitions contained therein. The undersigned have examined the resolutions adopted by the
Board of Directors of the Company. In the opinion of the undersigned, the undersigned have made such examination or investigation as is necessary to enable the undersigned to express an informed
opinion as to whether or not the conditions precedent to (i) the establishment of the Notes, (ii) the establishment of the forms of
the Notes and (iii) the authentication of the Notes, contained in the Indenture have been complied with. In the opinion of the undersigned, such conditions have been complied with. 

    Faegre &
Benson LLP and Dorsey & Whitney LLP are entitled to rely on this Officers' Certificate and Company Order in connection with the opinion they are rendering
pursuant to Sections 7(b) and 7(c), respectively, of the Underwriting Agreement. 

    IN
WITNESS WHEREOF, the undersigned have executed this Certificate this 16th day of November, 2000. 

	 	 	UNITEDHEALTH GROUP INCORPORATED
	 

 	 
 	 

/s/ ALLAN J. WEISS     
 Allan J. Weiss
 Vice President and Treasurer
	 

 

 	 
 
 	 

 

/s/ DAVID J. LUBBEN     
 David J. Lubben
 General Counsel and Secretary
	 

 

 	 
 
 	 

 

 

5

QuickLinks

Officers' Certificate and Company OrderPrepared by MERRILL CORPORATION www.edgaradvantage.com

QuickLinks
 -- Click here to rapidly navigate through this document
 

Draft 11-15-99

  Amendment dated as of November 15, 1999 to
  Indenture dated as of November 15, 1998
  by and between
  United HealthCare Corporation and
  The
Bank of New York, as Trustee         

    WHEREAS, United HealthCare Corporation, a Minnesota corporation (the "Company"), and The Bank of New York, a New York banking corporation (the "Trustee"),
previously entered into that Indenture dated as of November 15, 1998 (the "Indenture"), providing for the issuance of the Company's senior debt securities in one or more series; and 

    WHEREAS,
Section 1001(ix) of the Indenture provides that the Company and the Trustee may amend the Indenture without the consent of any Holders in order to cure any
defect in the Indenture, provided that such action does not adversely affect the interests of the Holders of any Securities of any Series in any material respect; and 

    WHEREAS,
the Company and the Trustee are entering into this Amendment pursuant to the foregoing Section 1001(ix). 

    NOW,
THEREFORE, the Company and the Trustee hereby agree as follows: 

    1.  Defined Terms. Capitalized terms which are used in this Amendment and which are not otherwise defined in this
Amendment have the meanings assigned to them in the Indenture. 

    2.  Amendments to Section 702. The references contained in the first and third sentences of Section 702 of
the Indenture to clauses (viii) and (ix) of Section 701 are hereby amended to become references to clauses (vi) and (vii) of Section 701. 

    3.  Ratification of Indenture as Amended. The Indenture, as amended by this Amendment, is hereby ratified and confirmed
as continuing in full force and effect. 

    IN
WITNESS WHEREOF, the parties have executed this Amendment as of the date first set forth above. 

	 	 	UNITED HEALTHCARE CORPORATION
	 

 	 
 	 

By	 

/s/ ALLAN J. WEISS   

	 	 	Name: Allan J. Weiss

Title: Vice President and Treasurer
	 

 	 
 	 
 THE BANK OF NEW YORK, as Trustee
	 

 	 
 	 

By	 

/s/ STEVEN GIURLANDO   

	 	 	Its	Vice President

QuickLinks

Amendment dated as of November 15, 1999 to Indenture dated as of November 15, 1998 by and between United HealthCare Corporation and The Bank of New York, as
Trustee

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00017-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00017-of-00352.parquet"}]]